Tag: #M&A

Kuva Labs, a specialist in cancer imaging, has entered into a binding agreement to acquire Lisata Therapeutics, a biotech firm... Read more

GSK has entered into a definitive agreement to acquire California-based RAPT Therapeutics for $58.00 per share, representing a total equity... Read more

Merger & Acquisition Update Verana Health, a real-world data (RWD) analytics firm, has announced the acquisition of oncology specialist COTA... Read more

Biopharmaceutical giant AbbVie has announced a definitive agreement to acquire a device manufacturing facility in Tempe, Arizona, along with associated... Read more

The global pharmaceutical market is abuzz with reports that Merck & Co. (MSD) is in active negotiations to acquire Revolution... Read more

U.S. biotech giant Amgen has agreed to acquire Oxford-based Dark Blue Therapeutics in a deal valued at up to $840... Read more

On January 8, 2026, Day One Biopharmaceuticals announced the formal completion of its acquisition of Mersana Therapeutics following the satisfaction... Read more

Eli Lilly has officially announced an agreement to acquire Ventyx Biosciences for $14 per share, totaling $1.2 billion. This strategic... Read more

Expanding Oncology Portfolio with Breakthrough Science On December 30, 2025, Johnson & Johnson (J&J) announced the completion of its acquisition... Read more